New study reveals hidden toll of vitiligo on chinese patients

NCT ID NCT07058051

Completed Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how vitiligo affects people in China, including their treatments and daily life. Researchers observed 100 patients to measure the disease's impact on their skin and quality of life. The goal was to better understand the real-world burden of this condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SEGMENTAL VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SEGMENTAL VITILIGO

Contacts and locations

Locations

Dermatology Hospital of Southern Medical University /ID# 276921

Guangzhou, Guangdong, 510091, China
Shandong Dermatological Hospital /ID# 276918

Jinan, Shandong, 250022, China
Suzhou Municipal Hospital /ID# 276948

Suzhou, Jiangsu, 215002, China
Wuhan Integrated TCM & Western Medicine Hospital（Wuhan No.1 Hospital) /ID# 276919

Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.